富国中证医药50ETF(515950)利润分配表
| |
2025-12-31 |
2025-06-30 |
2024-12-31 |
2024-06-30 |
| 收入 |
58,798,593.43 |
24,745,979.82 |
-95,463,489.19 |
-161,639,126.67 |
| 利息合计 |
10,069.65 |
4,964.65 |
358,811.55 |
345,365.78 |
| 其中:存款利息收入 |
10,069.65 |
4,964.65 |
19,438.39 |
9,961.65 |
| 债券利息收入 |
- |
- |
- |
- |
| 资产支持证券利息收入 |
- |
- |
- |
- |
| 买入返售金融资产收入 |
- |
- |
- |
- |
| 投资收益合计 |
5,898,905.54 |
-18,825,680.71 |
-102,255,032.18 |
-71,248,155.21 |
| 其中:股票投资收益 |
-3,870,580.49 |
-25,672,079.93 |
-116,019,538.90 |
-80,167,315.08 |
| 基金投资收益 |
- |
- |
- |
- |
| 债券投资收益 |
- |
- |
151,730.26 |
151,730.26 |
| 资产支持证券投资收益 |
- |
- |
- |
- |
| 衍生工具收益 |
- |
- |
- |
- |
| 股利收益 |
9,769,486.03 |
6,846,399.22 |
13,612,776.46 |
8,767,429.61 |
| 基金分红收益收益 |
- |
- |
- |
- |
| 公允价值变动收益 |
53,179,597.46 |
43,264,345.60 |
5,727,426.30 |
-91,323,074.67 |
| 其他收入 |
-289,979.22 |
302,350.28 |
705,305.14 |
586,737.43 |
| 费用 |
3,855,302.46 |
2,179,358.28 |
5,102,135.24 |
2,653,867.15 |
| 管理人报酬 |
2,896,550.98 |
1,640,680.44 |
3,781,994.98 |
1,972,587.45 |
| 基金托管费 |
579,310.20 |
328,136.04 |
756,399.07 |
394,517.56 |
| 销售服务费 |
- |
- |
- |
- |
| 交易费用 |
- |
- |
- |
- |
| 利息支出 |
- |
- |
- |
- |
| 其中:卖出回购金融资产支出 |
- |
- |
- |
- |
| 其他费用 |
379,441.28 |
210,541.80 |
562,517.97 |
285,553.21 |
| 利润总额 |
54,943,290.97 |
22,566,621.54 |
-100,565,624.43 |
-164,292,993.82 |
欢迎访问证券之星!请点此与我们联系 版权所有: Copyright © 1996-年